In new independent research reports released early this morning,
Capital Review released its latest key findings for all current
investors, traders, and shareholders of The Cooper Companies, Inc.
(NYSE:COO), Encompass Health Corporation (NYSE:EHC), SilverCrest
Metals Inc. (NYSE:SILV), Constellation Pharmaceuticals, Inc.
(NASDAQ:CNST), Leaf Group Ltd. (NYSE:LEAF), and TESSCO Technologies
Incorporated (NASDAQ:TESS), including updated fundamental
summaries, consolidated fiscal reporting, and fully-qualified
certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
COO DOWNLOAD: http://Capital-Review.com/register/?so=COO
EHC DOWNLOAD: http://Capital-Review.com/register/?so=EHC SILV
DOWNLOAD: http://Capital-Review.com/register/?so=SILV CNST
DOWNLOAD: http://Capital-Review.com/register/?so=CNST LEAF
DOWNLOAD: http://Capital-Review.com/register/?so=LEAF TESS
DOWNLOAD: http://Capital-Review.com/register/?so=TESS
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Capital Review,
available for free download at the links above, examine The Cooper
Companies, Inc. (NYSE:COO), Encompass Health Corporation
(NYSE:EHC), SilverCrest Metals Inc. (NYSE:SILV), Constellation
Pharmaceuticals, Inc. (NASDAQ:CNST), Leaf Group Ltd. (NYSE:LEAF),
and TESSCO Technologies Incorporated (NASDAQ:TESS) on a fundamental
level and outlines the overall demand for their products and
services in addition to an in-depth review of the business
strategy, management discussion, and overall direction going
forward. Several excerpts from the recently released reports are
available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
THE COOPER COMPANIES, INC. (COO) REPORT
OVERVIEW
The Cooper Companies' Recent Financial
Performance
For the three months ended January 31st, 2019 vs
January 31st, 2018, The Cooper Companies reported revenue of
$628.10MM vs $590.00MM (up 6.46%) and analysts estimated basic
earnings per share $2.09 vs -$2.50. For the twelve months ended
October 31st, 2018 vs October 31st, 2017, The Cooper Companies
reported revenue of $2,532.80MM vs $2,139.00MM (up 18.41%) and
analysts estimated basic earnings per share $2.85 vs $7.63 (down
62.65%). Analysts expect earnings to be released on June 6th, 2019.
The report will be for the fiscal period ending April 30th, 2019.
The reported EPS for the same quarter last year was $2.86. The
estimated EPS forecast for the next fiscal year is $13.26 and is
expected to report on December 5th, 2019.
To read the full The Cooper Companies, Inc. (COO) report,
download it here:
http://Capital-Review.com/register/?so=COO
-----------------------------------------
ENCOMPASS HEALTH CORPORATION (EHC) REPORT
OVERVIEW
Encompass Health's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Encompass Health reported revenue of
$1,096.00MM vs $1,008.80MM (up 8.64%) and analysts estimated basic
earnings per share $0.30 vs $0.76 (down 60.53%). For the twelve
months ended December 31st, 2018 vs December 31st, 2017, Encompass
Health reported revenue of $4,277.30MM vs $3,913.90MM (up 9.28%)
and analysts estimated basic earnings per share $2.98 vs $2.88 (up
3.47%). Analysts expect earnings to be released on April 25th,
2019. The report will be for the fiscal period ending March 31st,
2019. Reported EPS for the same quarter last year was $0.93. The
estimated EPS forecast for the next fiscal year is $3.92 and is
expected to report on February 6th, 2020.
To read the full Encompass Health Corporation (EHC) report,
download it here:
http://Capital-Review.com/register/?so=EHC
-----------------------------------------
SILVERCREST METALS INC. (SILV) REPORT
OVERVIEW
SilverCrest Metals' Recent Financial
Performance
Analysts expect earnings to be released on May
17th, 2019. The report will be for the fiscal period ending March
31st, 2019. The estimated EPS forecast for the next fiscal year is
-$0.06 and is expected to report on April 4th, 2019.
To read the full SilverCrest Metals Inc. (SILV) report, download
it here:
http://Capital-Review.com/register/?so=SILV
-----------------------------------------
CONSTELLATION PHARMACEUTICALS, INC. (CNST) REPORT
OVERVIEW
Constellation Pharmaceuticals' Recent Financial
Performance
Analysts expect earnings to be released on June
13th, 2019. The report will be for the fiscal period ending March
31st, 2019. The estimated EPS forecast for the next fiscal year is
-$3.34 and is expected to report on March 12th, 2020.
To read the full Constellation Pharmaceuticals, Inc. (CNST)
report, download it here:
http://Capital-Review.com/register/?so=CNST
-----------------------------------------
LEAF GROUP LTD. (LEAF) REPORT OVERVIEW
Leaf Group's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Leaf Group reported revenue of $45.52MM vs
$39.73MM (up 14.58%) and analysts estimated basic earnings per
share -$0.19 vs -$0.25. For the twelve months ended December 31st,
2018 vs December 31st, 2017, Leaf Group reported revenue of
$155.04MM vs $128.99MM (up 20.20%) and analysts estimated basic
earnings per share -$0.94 vs -$1.52. Analysts expect earnings to be
released on May 14th, 2019. The report will be for the fiscal
period ending March 31st, 2019.
To read the full Leaf Group Ltd. (LEAF) report, download it
here:
http://Capital-Review.com/register/?so=LEAF
-----------------------------------------
TESSCO TECHNOLOGIES INCORPORATED (TESS) REPORT
OVERVIEW
TESSCO Technologies' Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, TESSCO Technologies reported revenue of
$152.29MM vs $146.26MM (up 4.13%) and analysts estimated basic
earnings per share $0.32 vs $0.19 (up 68.42%). For the twelve
months ended March 31st, 2018 vs March 31st, 2017, TESSCO
Technologies reported revenue of $580.27MM vs $533.30MM (up 8.81%)
and analysts estimated basic earnings per share $0.62 vs $0.17 (up
264.71%). Analysts expect earnings to be released on May 6th, 2019.
The report will be for the fiscal period ending March 31st, 2019.
The reported EPS for the same quarter last year was $0.07. The
estimated EPS forecast for the next fiscal year is $0.77 and is
expected to report on May 6th, 2019.
To read the full TESSCO Technologies Incorporated (TESS) report,
download it here:
http://Capital-Review.com/register/?so=TESS
-----------------------------------------
ABOUT CAPITAL REVIEW
Capital Review is a nationally recognized
publisher of financial analysis, research reports, and exclusive
market reporting. Institutional investors, registered brokers,
professional traders, and personal investment advisers rely on
Capital Review to quantify public company valuations, discover
opportunity across asset classes, stay informed about market-moving
events, and read exclusive analysis of important material
developments. With 14 offices worldwide, Capital Review staffs and
manages certified and registered financial professionals, including
Chartered Financial Analyst® (CFA®) designation holders and FINRA®
BrokerCheck® certified individuals with current and valid CRD®
number designations, to enable continuous coverage of topics
relevant to its regular active reader base.
REGISTERED MEMBER STATUS
Capital Review's oversight and audit staff are
registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Capital Review's roster includes qualified
CFA® charterholders, licensed securities attorneys, and registered
FINRA® members holding duly issued CRD® numbers. Current licensed
status of several Registered Members at Capital Review have been
independently verified by an outside audit firm, including policy
and audit records duly executed by Registered Members. Complaints,
concerns, questions, or inquiries regarding this release should be
directed to Capital Review's Compliance department by Phone, at +1
(410) 280-7496, or by E-mail at compliance@Capital-Review.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Capital Review,
Capital Review members, and/or Capital Review affiliates are not
responsible for any gains or losses that result from the opinions
expressed. Capital Review makes no representations as to the
completeness, accuracy, or timeliness of the material provided and
all materials are subject to change without notice. Capital Review
has not been compensated for the publication of this press release
by any of the above mentioned companies. Capital Review is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Morena Zambada, Media Department
Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com
© 2019 Capital Review. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@Capital-Review.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.